About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04700852

Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis

This study is a proof o concept aiming to determine the efficacy of Puressentiel nasal protective spray (PNPS) in patients with allergic rhinitis. Cross over study, with a nasal provocative test (NPT...

Lead sponsor: Puressentiel•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Davide Caimmi, MD

CONTACT

33630061134 davide.caimmi@gmail.com

Elisabeth Simon, PhD

CONTACT

33144405528 e.simon@puressentiel.com

Sponsors

Lead Sponsor

Puressentiel

Collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•patients with diagnostic of allergic rhinitis sensitized to grass pollen for more than one year with or without associated asthma

Exclusion Criteria

•patients sensitized to a perrianual allergen
•patients with viral infection 4 weeks before inclusion
•patients with severe non controlled asthma
•patients with chronic sinusitis
•pregnancy or breast feeding
•patients with hypersensitivity to essential oil (eucalyptus radie)
•epileptic patient
•patients treated with nasal corticosteroid or anti-histamine

Related studies

RECRUITINGPhase 2/3

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

NCT06061848 · Allergic Rhinitis Due to Grass Pollen

COMPLETEDPhase 2

M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis

NCT06907680 · Allergic Rhinitis Due to Grass Pollens

COMPLETEDPhase 3

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy

NCT05191186 · Allergic Rhinitis Due to Grass Pollen, Allergic Conjunctivitis of Both Eyes, and more

Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber

NCT06104293 · Allergic Rhinitis Due to Grass Pollen

COMPLETEDPhase 1/2

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

NCT03290248 · Allergic Rhinitis, Allergic Rhinitis Due to Grass Pollen, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 8, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment15

Start dateFeb 2021

Last updatedJan 8, 2021

Condition

Allergic Rhinitis Due to Grass Pollen Allergic Inflammation

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2021Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions